THE MOST CENSORED WORK ONLINE!
The High Cost to EVERY American of Corruption at Johnson & Johnson
J&J has only *one* source of income: your wallet. The DOJ has only *one* source of income: your wallet. So, our wallets buy the products, pay insurance companies, pay to prosecute J&J, pay to defend J&J and then pay the fines. Everybody say: NO MORE! (tears)
Date Created: 2012, April 3
Keywords: pharma, healthcare, cost, insurance, lawsuit, corruption, profit, fraud
Site accessed :
This page accessed 365 times.
Johnson & Johnson has only one source of income: our wallets. Without us purchasing their products, such as toxic baby shampoo, insurance and taxes to pay for their diagnostic equipment for hospitals and home use and pharaceutical products, they'd have absolutely no cash. I hope that makes sense to you.
The Department of Justice (DOJ) has only one source of income: our wallets through taxation. This is the money used to pay the lawyers and judges to prosecute Johnson & Johnson for their crimes. See the Lawsuits page for the incomplete list of lawsuits brought against J&J by Whistleblowers.
The Medicaid program has only one source of income: our wallets thruogh taxation. As noted on the Lawsuits page, J&J has stolen our money from Medicaid in many illegal ways such as higher priced drugs, going back on promised reductions in drug prices and off-label marketing of harmful drugs to children and the elderly - causing the recipients of this illegal marketing and sales permanent health harms that cost us even more money for even more drugs to treat for the rest of their lives.
In April of 2011, Johnson & Johnson gave $150 million to support ObamaCare. Considering J&J has only one source of income, our wallets, increased prices for consumer goods, diagnostic equipment and pharmaceuticals was used to pay for this support. I wonder if there was a little bribe money or bonuses to Obama for that - considering Obama's less-than-ethical past with regard to investments and J&J's obvious support of bribery and kickbacks with the numerous lawsuits and convications for such, it wouldn't be surprising.
While JNJ profits should cover the expense of lawyers, fines, compensation, etc, executive salaries are not cut to reflect the harm, and shareholders are continuing to enjoy stock that continues to rise - only because of profits gained from illegal and unethical activity of Johnson & Johnson employees and executives.
So, if profits are still rising, shareholders are still getting an increase in dividends and executives continue to earn outrageous salaries (Bill Weldon alone received more than $30 million compensation in 2011), where is the money coming from to pay the lawyers and penalties? It's got to be from inflated prices of consumer goods, diagnostic equipment and pharmaceutical products - OUR wallets.
When you look at the fact that healthcare costs are associated with 50% of foreclosures and 60% of bankruptcies, JNJ is emptying our wallets, our banks and putting a huge strain on our medical system.
At what point will the expense of JNJ's crimes through higher taxes and health care costs outweigh the profit for shareholders? When you add up the increases in health care costs in private pay prices, health insurance prices and increases in taxes to cover the uninsured and underinsured, it probably already has...
INDEPENDENT AD-FREE WORK Most recent gift: 15 November 2023
This work is not
sponsored by bankers, lawyers, gov agencies, ad agencies or fraudsters.
Your gift, no matter the size, makes a real difference.
Please consider contributing today to help me continue work exposing fraud, corruption, coverups and harmful, defective and toxic products. Together, we can create a positive impact for improved health and well-being that lasts.
Thank you for your generosity,
PROCESSED ON TRANSACTION PROVIDER SECURE SERVERS
PayPal: Log in or scroll to bottom of PayPal transaction page and click "Pay with Debit or Credit Card"
1. Emily Patterson (2012, March 9). Risky Products Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/products.shtml
2. Emily Patterson (2012, March 9). Johnsno & Johnson Global Lawsuits Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/lawsuits.shtml
3. Emily Patterson (2012, March 9). Numerous Whistleblowers Come Forward Against Johnson & Johnson Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/whistleblowers.shtml
4. Emily Patterson (2012, March 9). Johnsno & Johnson Global Lawsuits Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/lawsuits.shtml
5. David Almasi, Judy Kent (2011, April 27). Shareholders to Challenge Johnson & Johnson's Support for Left-Wing Policy Agenda: CEO William C. Weldon to Be Questioned on Firm's Failure to Disclose Financial Information on Firm's ObamaCare Lobbying It Pledged to Release Last Year PRNewsWire. Retrieved from http://www.prnewswire.com/news-releases/shareholders-to-challenge-johnson--johnsons-support-for-left-wing-policy-agenda-ceo-william-c-weldon-to-be-questioned-on-firms-failure-to-disclose-financial-information-on-firms-obamacare-lobbying-it-pledged-to-release-last-120789714.html
6. Emily Patterson (2012, October 28). Rising Health Care Costs Fueling 50% of Foreclosures and Economic Crisis Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/healthcare_foreclosures.shtml
7. Emily Patterson (2012, October 28). Skyrocketing Healthcare Costs are Driving 60% of Bankruptcies Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/healthcare_bankruptcies.shtml
CENSOR AVOIDANCE SYSTEM
Since I can't share my work on social media basically at all anymore, resorting to the last remaining free-ish solution to share my work: